Back to
JONES FINANCIAL COMPANIES LLLP
QNCX
3 quarters
Position history for
JONES FINANCIAL COMPANIES LLLP's holdings in QUINCE THERAPEUTICS INC
As of its Q1 2026 13F, Jones Financial Companies held 133 shares of QNCX (Quince Therapeutics), worth $12. Jones Financial Companies' 13F filings listed QNCX from Q4 2025 to Q1 2026, 2 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$446
Total Shares Change
-133
Quarter-by-Quarter History